SEC Form 4 · accession 0001660483-17-000007
DUPONT E I DE NEMOURS & CO · DD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Marc Doyle
Officer — Executive Vice President
Period of report
Aug 31, 2017
Accepted (ET)
Sep 5, 2017 · 5:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000030554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 31, 2017 | D | 72,882 | — | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (right to buy)F2 | $59.6543 | Aug 31, 2017 | D | 3,161 | D | — | Feb 4, 2021 | Common Stock | 3,161 | 0 | D |
| Employee Stock Options (right to buy)F3 | $71.0648 | Aug 31, 2017 | D | 17,891 | D | — | Feb 3, 2022 | Common Stock | 17,891 | 0 | D |
| Employee Stock Options (right to buy)F4 | $58.76 | Aug 31, 2017 | D | 44,777 | D | — | Feb 2, 2026 | Common Stock | 44,777 | 0 | D |
| Employee Stock Options (right to buy)F5 | $76.17 | Aug 31, 2017 | D | 48,049 | D | — | Feb 1, 2027 | Common Stock | 48,049 | 0 | D |
Explanation of responses
- F1Disposed of pursuant to merger agreement between issuer and Dow Chemical Company in exchange for 93,433 shares or stock units, as applicable, of DowDuPont common stock having a market value of $67.18 per share or stock unit, as applicable, on the effective date of the merger.
- F2This option, which provided for vesting in three equal annual installments beginning February 5, 2015, was assumed by DowDuPont in the merger and exchanged for 4,052 options at a grant price of $46.54.
- F3This option, which provided for vesting in three equal annual installments beginning February 4, 2016, was assumed by DowDuPont in the merger and exchanged for 22,936 options at a grant price of $55.44.
- F4This option, which provided for vesting in three equal annual installment beginning February 3, 2017, was assumed by DowDuPont in the merger and exchanged for 57,404 options at a grant price of $45.84.
- F5This option, which provided for vesting in three equal annual installments beginning February 2, 2018, was assumed by DowDuPont in the merger and exchanged for 61,598 options at a grant price of $59.42.